Create Alert
Watchlist

Divi's Laboratories

₹6,452.50
+72.50 (1.14%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
6,410.00
Prev. Close
6,380.00
Volume
5,36,205
Total traded value
346 Cr
Upper Circuit
7,018.00
Lower Circuit
5,742.00

Fundamentals

Market Cap₹1,69,385Cr
ROE16.12%
P/E Ratio(TTM)68.16
EPS(TTM)93.61
P/B Ratio10.99
Dividend Yield0.47%
Industry P/E33.18
Book Value580.60
Debt to Equity0.01
Face Value2
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Divi's Labs

Divi's Laboratories is a prominent global manufacturer specializing in Active Pharmaceutical Ingredients (APIs), Custom Synthesis for innovator companies, and high-quality Nutraceutical ingredients. The company's vision is to create lasting value for its stakeholders by producing superior generic APIs and custom intermediates for the global pharmaceutical and nutraceutical industries. It aims to be a responsible business, adding value through its expertise in chemistry and serving the community with diverse social initiatives for a better future. As an API-exclusive manufacturer, Divi's focuses solely on producing ingredients and does not compete with its customers by marketing the final medicine formulations. A key operational strength is its backward-integrated model, which allows the company to produce most key starting materials internally, ensuring quality and supply security. This business model has made Divi's a trusted global supplier to pharmaceutical companies across more than 100 countries, with exports making up 88% of its revenue.;
Parent OrganisationDivi's Laboratories Limited
Managing DirectorDr. Kiran S. Divi
Founded1990
NSE SymbolDIVISLAB

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
51.89%
Foreign Institutions
19.39%
Mutual Funds
13.99%
Retail And Others
8.96%
Other Domestic Institutions
5.77%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Neuland Laboratories
NA
(0.00%)
84.50
Jubilant Pharmova
NA
(0.00%)
35.37
Acutaas Chemicals
NA
(0.00%)
59.16
Gujarat Themis Biosyn
NA
(0.00%)
87.97
2025
7
Nov
Quarterly Result
Release date
6
Aug
Quarterly Result
Release date

25
Jul
Dividend
Ex date
₹30.00
per share

For each share you hold, you will receive ₹30.00
Dividend amount₹30.00 per share
Dividend TypeFinal
Ex Date25 Jul ‘25
Record Date25 Jul ‘25
Announcement date17 May ‘25

17
May
Dividend
Announced
₹30.00
per share

For each share you hold, you will receive ₹30.00
Dividend amount₹30.00 per share
Dividend TypeFinal
Ex Date25 Jul ‘25
Record Date25 Jul ‘25
Announcement date17 May ‘25
17
May
Annual Result
Release date
3
Feb
Quarterly Result
Release date
2024
9
Nov
Quarterly Result
Release date
3
Aug
Quarterly Result
Release date

2
Aug
Dividend
Ex date
₹30.00
per share

For each share you hold, you will receive ₹30.00
Dividend amount₹30.00 per share
Dividend TypeFinal
Ex Date2 Aug ‘24
Record Date2 Aug ‘24
Announcement date25 May ‘24

25
May
Dividend
Announced
₹30.00
per share

For each share you hold, you will receive ₹30.00
Dividend amount₹30.00 per share
Dividend TypeFinal
Ex Date2 Aug ‘24
Record Date2 Aug ‘24
Announcement date25 May ‘24
25
May
Result
Release date
Events calendar
View upcoming events in other stocks